A detailed history of Acadian Asset Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 127,404 shares of STIM stock, worth $177,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
127,404
Previous 326,975 61.04%
Holding current value
$177,091
Previous $587,000 83.65%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$0.73 - $2.0 $145,686 - $399,142
-199,571 Reduced 61.04%
127,404 $96,000
Q2 2024

Aug 06, 2024

BUY
$1.73 - $4.81 $108,346 - $301,240
62,628 Added 23.69%
326,975 $587,000
Q1 2024

May 10, 2024

SELL
$2.68 - $4.8 $91,580 - $164,025
-34,172 Reduced 11.45%
264,347 $1.26 Million
Q4 2023

Feb 13, 2024

SELL
$1.05 - $2.9 $74,534 - $205,856
-70,985 Reduced 19.21%
298,519 $864,000
Q3 2023

Nov 13, 2023

SELL
$1.29 - $2.22 $67,237 - $115,710
-52,122 Reduced 12.36%
369,504 $498,000
Q2 2023

Aug 07, 2023

BUY
$2.07 - $2.92 $12,701 - $17,917
6,136 Added 1.48%
421,626 $905,000
Q1 2023

May 11, 2023

BUY
$2.81 - $6.71 $1.05 Million - $2.51 Million
373,782 Added 896.19%
415,490 $1.21 Million
Q4 2022

Feb 14, 2023

BUY
$2.74 - $6.87 $104,180 - $261,211
38,022 Added 1031.52%
41,708 $284,000
Q3 2022

Nov 14, 2022

BUY
$2.35 - $4.66 $8,662 - $17,176
3,686 New
3,686 $11,000
Q4 2021

Feb 10, 2022

SELL
$3.87 - $6.59 $15,077 - $25,674
-3,896 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$6.22 - $15.54 $24,233 - $60,543
3,896 New
3,896 $25,000
Q2 2020

Aug 12, 2020

SELL
$1.41 - $2.61 $32,214 - $59,630
-22,847 Closed
0 $0
Q1 2020

May 11, 2020

BUY
$1.28 - $4.5 $29,244 - $102,811
22,847 New
22,847 $43,000

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $37.6M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.